Replies to post #22940 on Ayala Pharmaceuticals Inc (ADXS)

[JB-22]

This is why you get cash upfront.

This is a big F UP from management.

[shub]

JB:
If we can get RU marketing approval for AXAL, produce it ourselves and put it out there boasting an unprecedented 39% survival rate...Folks will come to us to buy it in growing numbers.
With that cash flow to fund the dual trials, we will have a solid product with solid patent and IP before the protection on AXAL runs out.